SYCREST

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Italy, Japan, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug SYCREST contains one active pharmaceutical ingredient (API):

1	Asenapine UNII CU9463U2E2 - ASENAPINE MALEATE
	The mechanism of action of asenapine is not fully understood. However, based on its receptor pharmacology, it is proposed that the efficacy of asenapine is mediated through a combination of antagonist activity at D2 and 5-HT2A receptors. Actions at other receptors e.g. 5-HT1A, 5-HT1B, 5-HT2C, 5-HT6, 5-HT7, D3, and a2-adrenergic receptors, may also contribute to the clinical effects of asenapine.
	Read more about Asenapine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SYCREST Sublingual tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AH05	Asenapine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1491296, 1491308, 1491319, 1491353, 1491364, 1491375
ES	Centro de información online de medicamentos de la AEMPS	10640002, 10640005
FI	Lääkealan turvallisuus- ja kehittämiskeskus	144035, 444041, 459766, 513474
FR	Base de données publique des médicaments	61455009, 65697814
GB	Medicines & Healthcare Products Regulatory Agency	194964, 194967
IE	Health Products Regulatory Authority	31008, 31009
IT	Agenzia del Farmaco	040761013, 040761025, 040761037, 040761049, 040761052, 040761064
JP	医薬品医療機器総合機構	1179056F1021, 1179056F2028
LT	Valstybinė vaistų kontrolės tarnyba	1056399, 1056400, 1056401, 1056402, 1056403, 1056404
PL	Rejestru Produktów Leczniczych	100229900, 100229917
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W56547001, W56547002, W56547003, W56548001, W56548002, W56548003